$LJPC

La Jolla Pharmaceutical Co.

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

PRICE

$3.12 β–Ό-2.194%

Last Close

VOLUME

118,773

DAY RANGE

3.11 - 3.2

52 WEEK

3.1 - 5.08

Join Discuss about LJPC with like-minded investors

JO
@jooppp #StockTraders.NET
recently

stop loss $LJPC at 4.97 very disappointed

42 Replies 15 πŸ‘ 8 πŸ”₯

JO
@jooppp #StockTraders.NET
recently

still wait for bounce $LJPC

121 Replies 9 πŸ‘ 9 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

disappointed with $LJPC, it had a good potential, but...

129 Replies 15 πŸ‘ 8 πŸ”₯

JO
@jooppp #StockTraders.NET
recently

Long $LJPC at 5.2 for fun

47 Replies 12 πŸ‘ 14 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$LJPC a bottom is in IMO

64 Replies 7 πŸ‘ 15 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

πŸ‘‡ > @TraderXx said: $LJPC nxt lvl 5.18

119 Replies 9 πŸ‘ 8 πŸ”₯

WI
@WINTERTRADE #StockTraders.NET
recently

$ljpc lower

45 Replies 6 πŸ‘ 13 πŸ”₯

WI
@WINTERTRADE #StockTraders.NET
recently

didnt trade $plug but traded $zom $ljpc $actc $bmra $riot today

60 Replies 10 πŸ‘ 13 πŸ”₯

profile
@Neptune5045 #StockTraders.NET
recently

like $LJPC not easy trade

40 Replies 8 πŸ‘ 15 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

the way to attack $LJPC is, you need sizable range move before you can trade it, this tiny up and down action is what we call a no mans land

139 Replies 10 πŸ‘ 11 πŸ”₯

profile
@Math #StockTraders.NET
recently

$LJPC careful cancer action - recipe for disaster generally. Don't be overly bias

69 Replies 6 πŸ‘ 11 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$LJPC nxt lvl 5.18

130 Replies 11 πŸ‘ 15 πŸ”₯

profile
@Math #StockTraders.NET
recently

$LJPC careful there

129 Replies 13 πŸ‘ 8 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

this is what I am waiting on $LJPC

133 Replies 8 πŸ‘ 11 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

too choppy > @TraderXx said: $LJPC does look like a liquidity trap to me so far

86 Replies 11 πŸ‘ 15 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$LJPC does look like a liquidity trap to me so far

67 Replies 15 πŸ‘ 7 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$LJPC anyone?

139 Replies 7 πŸ‘ 15 πŸ”₯

Key Metrics

Market Cap

79.74 M

Beta

0.74

Avg. Volume

54.34 K

Shares Outstanding

25.56 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-04

Next Dividend Date

Company Information

La Jolla Pharmaceutical Company is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases. In December 2017, GIAPREZAβ„’ (angiotensin II) was approved by the U.S. Food and Drug Administration (FDA) as a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. In August 2019, GIAPREZA was approved by the European Commission (EC) for the treatment of refractory hypotension in adults with septic or other distributive shock who remain hypotensive despite adequate volume restitution and application of catecholamines and other available vasopressor therapies. LJPC-0118 (artesunate) is La Jolla's investigational product for the treatment of severe malaria.

Website:

HQ: 4550 Towne Centre Ct San Diego, 92121-1900 California

Related News